Survey on the organization and techniques of ATMP facilities by DARE-NL, EBMT, T2Evolve, and NXTGEN-HIGHTECH - a GoCART-coalition initiative

Open survey page

Study type:

Surveys

Study number:

8420041

Type of Stem Cell Treatment:

CAR T

Gene Therapy

Cellular therapies (other than DLI)

Diseases:

All diseases

Short title:

Primary objective:

Key inclusion criteria:

Facility (operations) managers, production (operations) managers, quality assurance managers and quality control managers engaged in cell and gene therapy activities.

Country:

All EBMT member countries

Principal investigator:

EBMT Study Unit:

Leiden Study Unit

Reason for processing personal data:

Not applicable to surveys

Categories of personal data collected:

Not applicable to surveys

Recipients who may access the data:

Not applicable to surveys

3rd-party processors of Personal Data on behalf of EBMT/Service provider:

Not applicable to surveys

Privacy notices

Article 6 lawful basis for processing personal data:

Article 6.1 (a) - Consent (Collection)

Article 9 basis for processing special category data:

Article 9(2) (a) - Consent (Collection)

Data Protection Impact Assessments

Rights available to individuals:

Access

Data portability

Rectification

Objection

Deletion

Is a Data Protection Impact Assessment required?:

Not applicable to surveys

Retention Schedule (if possible):

Not applicable to surveys